Jagsonpal Pharmaceuticals Ltd Announces 46th AGM, Reports 28.8% Revenue Growth in FY 2024-25

Jagsonpal Pharmaceuticals Ltd has announced that its 46th Annual General Meeting (AGM) will be held on September 24, 2025, through Video Conferencing (VC)/ Other Audio Visual Means (OAVM). The company has provided the facility for remote e-voting and e-voting at the AGM for members holding shares as on the cut-off date. The AGM Notice and Annual Report for the Financial Year 2024-25 have been sent to all the members of the company. The company reported a 28.8% increase in revenue, operational EBITDA margin at 411 bps, and operational PAT at 319 bps in FY 2024-25.